Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis

Journal of Rheumatology

Volumn 37, Issue 9, 2010, Pages 1871-1877

  Walkey, Allan J ^a   Ieong, Michael ^a   Alikhan, Mir ^a   Farber, Harrison W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pulmonary hypertension; Systemic scleroderma

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; COHORT ANALYSIS; DIASTOLIC DYSFUNCTION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VITAL CAPACITY;

CARDIOVASCULAR SYSTEM; COHORT STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; MALE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 77956461669     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.091424     Document Type: Article

References (21)

1. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283-9.
2. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna, et al. Systemic sclerosis: Demographic, clinical and serologic features and survival in 1012 Italian patients. Medicine Baltimore 2002;81:139-53.
3. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2010;39:269-77.
4. Owens GR, Follansbee WP. Cardiopulmonary manifestations of systemic sclerosis. Chest 1987;91:118-27.
5. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006;354:2655-66.
6. Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000;132:425-34.
7. Hachulla E, Coghlan JG. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism. Ann Rheum Dis 2004;63:1009-14.
8. DePaso WJ, Winterbauer RH, Lusk JA, Dreis DF, Springmeyer SC. Chronic dyspnea unexplained by history, physical examination, chest roentgenogram, and spirometry. Analysis of a seven-year experience. Chest 1991;100:1293-9.
9. Martinez FJ, Stanopoulos I, Acero R, Becker FS, Pickering R, Beamis JF. Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest 1994;105:168-74.
10. Sue DY, Wasserman K. Impact of integrative cardiopulmonary exercise testing on clinical decision making. Chest 1991;99:981-92.
11. Markowitz DH, Systrom DM. Diagnosis of pulmonary vascular limit to exercise by cardiopulmonary exercise testing. J Heart Lung Transplant 2004;23:88-95.
12. Tolle JJ, Waxman AB, Van Horn TL, Pappagioanopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation 2008;118:2183-9.
13. Steen V, Chou M, Shanmugam V, Mathias M, Kuru T, Morrissey R. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008;134:146-51.
14. Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, et al. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008;35:458-65.
15. Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation: Including pathophysiology and clinical applications. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1999.
16. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:40S-47S.
17. Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009;54:S55-66.
18. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90.
19. Chua TP, Clark AI, Amadi AA, Coats AJ. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996;27:650-7.
20. Silverstein JL, Steen VD, Medsger TA Jr, Falanga V. Cutaneous hypoxia in patients with systemic sclerosis (scleroderma). Arch Dermatol 1988;124:1379-82.
21. Farber HW, Graven KK, Kokolski G, Korn JH. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma. J Rheumatol 1999;26:1195-6.